ampicillin sodium; sulbactam sodium · Pfizer · NDA 050608
Unasyn
Earliest generic entry, as listed · earliest of 3 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 4
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 050608 · 001 · RLD | injectable, injection | EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL | open |
| 050608 · 002 · RLD | injectable, injection | EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL | open |
| 050608 · 003 · discontinued | injectable, injection | EQ 500MG BASE/VIAL;EQ 250MG BASE/VIAL | open |
| 050608 · 005 · RLD | injectable, injection | EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL | open |